(Q69382920)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4632688%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

title

The alternate pathway of complement activation. The role of C3 and its inactivator (KAF) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4632688%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

author name string

Nicol PA

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4632688%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

Lachmann PJ

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4632688%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

publication date

1 February 1973

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4632688%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4632688%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4632688%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4632688%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

page(s)

259-275

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4632688%20AND%20SRC:MED&resulttype=core&format=json

Antigenic determinants of human beta-1c and beta-1g-globulins.

1 October 2019

cites work

1 reference

12 December 2020

A new concept of immunosuppression in hypersensitivity reactions and in transplantation immunity

1 reference

12 December 2020

The preparation and properties of alexinated intermediates that react with conglutinin. I. Guinea-pig complement

1 reference

12 December 2020

A plasmin-split fragment of C'3 as a new chemotactic factor

1 reference

12 December 2020

Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum

1 reference

12 December 2020

Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients

1 reference

12 December 2020

The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement

1 reference

12 December 2020

C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3

1 reference

12 December 2020

Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum

1 reference

12 December 2020

C3 leukotactic factors produced by a tissue protease

1 reference

12 December 2020

Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them

1 reference

12 December 2020

Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection

1 reference

12 December 2020

Isolation and properties of a glycine-rich β-glycoprotein of human serum

1 reference

12 December 2020

The purification of specific antibody as F(ab')2 by the pepsin digestion of antigen-antibody precipitates, and its application to immunoglobulin and complement antigens.

1 reference

12 December 2020

Deficiency of C3 inactivator in man

1 reference

12 December 2020

The C3-activator system: an alternate pathway of complement activation

1 reference

12 December 2020

C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.

1 reference

12 December 2020

Isolation of the anticomplementary protein from cobra venom and its mode of action on C3

1 reference

12 December 2020

An Alternate Complement Pathway: C-3 Cleaving Activity, Not Due to [unk], on Endotoxic Lipopolysaccharide after Treatment with Guinea Pig Serum; Relation to Properdin

1 reference

12 December 2020

Genetic polymorphism in human glycine-rich beta-glycoprotein

1 reference

12 December 2020

C3b inactivator of man. 3. Further purification and production of antibody to C3b INA

1 reference

12 December 2020

C3 inactivating factor in the serum of a patient with chronic hypocomplementaemic proliferative glomerulo-nephritis

1 reference

12 December 2020

C3 proactivator convertase and its mode of action

1 reference

12 December 2020

Inactivator of the Third Component of Complement as an Inhibitor in the Properdin Pathway

1 reference

12 December 2020

Complement fixation by the F(ab')2-fragment of pepsin-treated rabbit antibody

1 reference

12 December 2020

The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena

1 reference

12 December 2020

The properdin system and immunity. XIII. Assay and properties of a heat-labile serum factor (factor B) in the properdin system

1 reference

12 December 2020

The properdin system and immunity. XII. Assay, properties and partial purification of a hydrazine-sensitive serum factor (factor A) in the properdin system

1 reference

12 December 2020

ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS

1 reference

12 December 2020

Identifiers

1 reference